Quan Anh Vu
Net worth: 195 802 $ as of 2024-04-29
Career history of Quan Anh Vu
Former positions of Quan Anh Vu
Companies | Position | Start | End |
---|---|---|---|
OCUGEN, INC. | Comptroller/Controller/Auditor | 2023-03-09 | 2023-08-13 |
Director of Finance/CFO | 2023-03-05 | 2023-08-13 | |
Corporate Officer/Principal | 2023-01-31 | 2023-03-05 | |
180 LIFE SCIENCES CORP. | Chief Operating Officer | 2021-10-28 | 2023-01-17 |
Solganick & Co., Inc. | Corporate Officer/Principal | 2019-08-31 | 2021-09-30 |
Baleena Bioscience, Inc. | Corporate Officer/Principal | 2021-03-31 | 2021-09-30 |
OPIANT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2016-08-31 | 2019-07-31 |
Training of Quan Anh Vu
University of California, Los Angeles | Undergraduate Degree |
Statistics
International
United States | 6 |
2 |
Operational
Corporate Officer/Principal | 4 |
Undergraduate Degree | 1 |
Chief Operating Officer | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
OCUGEN, INC. | Health Technology |
180 LIFE SCIENCES CORP. | Health Technology |
Private companies | 3 |
---|---|
Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
Solganick & Co., Inc. | Finance |
Baleena Bioscience, Inc. |
- Stock Market
- Insiders
- Quan Anh Vu
- Experience